Immediate Impact

55 standout
Sub-graph 1 of 22

Citing Papers

Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer (TOPAZ-1): patient-reported outcomes from a randomised, double-blind, placebo-controlled, phase 3 trial
2024 Standout
Nucleolin lactylation contributes to intrahepatic cholangiocarcinoma pathogenesis via RNA splicing regulation of MADD
2024 Standout
2 intermediate papers

Works of Charlotte Rees being referenced

Cediranib or placebo in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer (ABC-03): a randomised phase 2 trial
2015

Author Peers

Author Last Decade Papers Cites
Charlotte Rees 138 231 196 9 306
Nikolas Tsavaris 125 107 191 11 323
Francesca Abbati 124 205 187 16 318
S. Provent 206 309 211 7 352
Luca Tondulli 109 104 170 14 278
Fernando Bonadeo 78 177 249 10 300
Douglas G. Gold 136 136 95 10 315
Maria Koumpou 121 142 134 12 310
F. Daniel 174 145 229 13 370
Jit-Fong Lim 69 211 233 7 323
T.H. Khor 65 146 189 10 345

All Works

Loading papers...

Rankless by CCL
2026